Developer docs
API playgroundTry for free, no card

Search company profiles

Medtronic Ltd

Full company profile

uuid004vhgr

Namestring
Medtronic Ltd
Legal namestring
Medtronic Limited
Company typeenum
Private
Founded yearstring
-
Descriptiontext

Medtronic Ltd is the UK operating entity of Medtronic plc (NYSE: MDT), trading under the consumer-facing MiniMed brand and headquartered in Watford, Hertfordshire. The entity operates Medtronic's diabetes business for the United Kingdom only, with related manufacturing at Medtronic MiniMed Inc. (US) and EMEA distribution coordinated through Medtronic International Trading sàrl (Switzerland) and Medtronic BV (Netherlands). Its core offering is an integrated diabetes management ecosystem spanning insulin pump therapy (MiniMed 780G with SmartGuard auto-adjusting algorithm), continuous glucose monitoring (Guardian 4, Simplera), smart insulin pens (InPen, MiniMed Go), and a broad infusion set and reservoir portfolio including the first 7-day wear Extended infusion set. Underlying these devices are the CareLink Personal data platform for therapy reporting and the WeCare personalized onboarding and 24/7 support program, which together aggregate pump, CGM, and pen data from a large installed base.

The business model is a hybrid of regulated medical device hardware sales and recurring software/services revenue. Hardware revenue comes from pump, CGM, smart pen, reservoir, and infusion set sales, with the Extended infusion set and matching reservoir creating a weekly rather than twice-weekly consumables cycle. Software and services revenue is generated through CareLink Personal and the WeCare subscription-style support program. Distribution is dual-track: NHS-funded devices are prescribed and initiated through healthcare professionals (HCPs), with a dedicated HCP portal at hcp.medtronic-diabetes.com, while self-funded patients purchase directly through the UK eShop (self-funded-shop.medtronic-diabetes.co.uk). Customer segments are primarily people with Type 1 diabetes on pump therapy, people with Type 2 diabetes on multiple daily injections (addressed via Smart MDI and MiniMed Go), and the HCPs who prescribe and manage them. The UK entity employs 125 people and operates in a single geography, with growth dependent on NHS commissioning, NICE guideline evolution, and direct-to-consumer channel scaling.

Short descriptiontext

Medtronic Ltd is the UK subsidiary of Medtronic plc, trading as MiniMed. It distributes an integrated diabetes ecosystem — insulin pumps, CGMs, smart pens, and the CareLink data platform — serving Type 1 and Type 2 diabetes patients in the UK via NHS and direct eShop channels.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersWatford, United Kingdom
HQ citystring
Watford
HQ countrystring
United Kingdom
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
insulin pump therapy, continuous glucose monitoring, diabetes management devices, smart insulin pen, hybrid closed loop systems
Industry7 codes
PRIMARYHLAHAHAF
Automated Insulin Delivery (AID) / Closed-Loop Systems
Healthcare & Life Sciences/Medical Devices & Diagnostics/Diabetes Care Devices (CGM, Insulin Delivery)
SECONDARYHLAHAIAG
Insulin Pumps & Patch Pumps
Healthcare & Life Sciences/Medical Devices & Diagnostics/Drug Delivery Devices (Injectors, Pumps, Inhalers)
SECONDARYHLAHAHAB
Insulin Pumps (Tubed)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Diabetes Care Devices (CGM, Insulin Delivery)
SECONDARYHLAHAHAD
Smart Insulin Pens & Connected Pen Caps
Healthcare & Life Sciences/Medical Devices & Diagnostics/Diabetes Care Devices (CGM, Insulin Delivery)
SECONDARYHLAHAHAE
Insulin Pen Needles, Syringes & Infusion Sets (Consumables)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Diabetes Care Devices (CGM, Insulin Delivery)
SECONDARYHLAHAHAL
Diabetes Care Device Accessories & Adhesives (Sensors/Pump Supplies)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Diabetes Care Devices (CGM, Insulin Delivery)
SECONDARYHLAHAHAJ
Diabetes Digital Therapeutics & Dose Decision Support (Bolus Calculators)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Diabetes Care Devices (CGM, Insulin Delivery)
NAICS code3 codes
  • Surgical Appliance and Supplies Manufacturing339113
  • Surgical and Medical Instrument Manufacturing339112
  • Navigational, Measuring, Electromedical, and Control Instruments Manufacturing33451
SIC code2 codes
  • Surgical & Medical Instruments & Apparatus3841
  • Electromedical & Electrotherapeutic Apparatus3845
Product category
Diabetes Management Devices
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model3 records
1Medical Device Hardware Sales
TypeHardware Sales
Description

Sale of insulin pumps (MiniMed 780G, MiniMed 640G, MiniMed 670G), continuous glucose monitors, smart insulin pens, infusion sets, and consumables through direct eShop channel and healthcare provider prescriptions.

medtronic-diabetes.com
2Software and Data Services
TypeSubscription Recurring
Description

CareLink Personal cloud platform for device data management, WeCare support services providing personalized onboarding and 24/7 assistance, and mobile app ecosystem.

medtronic-diabetes.com
3Extended Infusion Set and Reservoir Consumables
TypeHardware Sales
Description

Proprietary 7-day Extended Infusion Set and matching 3.0ml reservoir designed exclusively for use with the Medtronic Extended system, requiring weekly rather than twice-weekly changes.

medtronic-diabetes.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Supply Chain, Personnel, Operations, Marketing or Sales
GTM typeB2B and B2C
B2B and B2C
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 8 records shown
1WeCare
Description

Personalised onboarding programs and 24/7 support services for diabetes patients using Medtronic devices.

medtronic-diabetes.com
+7 more records
Core offering1 text field

Medtronic Ltd operates the UK diabetes business under the MiniMed brand, designing, manufacturing, and selling insulin pumps (MiniMed 780G system), continuous glucose monitors (Guardian 4 and Simplera), the InPen smart insulin pen, infusion sets (Mio Advance, Mio 30, Quick-set, Silhouette, Sure-T, Extended), reservoirs, and supporting software platforms (CareLink Personal, WeCare, MiniMed Mobile and CareLink Connect apps) for people with Type 1 and insulin-requiring Type 2 diabetes.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Users achieve mean 80% Time In Range (TIR) with MiniMed 780G using recommended settings
+2 more records
Product overview1 text field

Medtronic Ltd (trading as MiniMed) is the insulin delivery division of Medtronic, offering an integrated ecosystem of diabetes management products. The core offering is the MiniMed 780G system — a hybrid closed-loop insulin pump that automatically adjusts basal insulin delivery based on CGM data. For patients preferring multiple daily injections, the Smart MDI system combines Simplera CGM with the InPen smart insulin pen. The product portfolio spans multiple device categories: insulin pumps (MiniMed 780G), smart insulin pens (InPen, MiniMed Go), CGM sensors (Guardian 4, Simplera), infusion sets (Medtronic Extended, Mio Advance, Mio 30, Quick Set, Silhouette, Sure-T), reservoirs, and injection ports (i-Port Advance). These devices are unified through the CareLink data management platform, which aggregates pump, CGM, and smart pen data for patients and healthcare providers, and supported by the WeCare patient onboarding and support program.

Product and service15 records
1MiniMed 780G System
CategoryInsulin pump therapy
Description

Automated insulin delivery system for people with Type 1 diabetes, combining an insulin pump, CGM integration, and a hybrid closed-loop control algorithm to automatically adjust basal insulin and correct highs.

2Smart MDI System
CategorySmart insulin pen therapy
Description

Connected insulin pen and CGM-based system for people with insulin-requiring diabetes who manage their condition with multiple daily injections rather than a pump.

3InPen System
CategorySmart insulin pen therapy
Description

Bluetooth-enabled smart insulin pen that records insulin doses, calculates dose recommendations, and shares data with the companion mobile app for MDI users.

4Guardian 4 Sensor
CategoryContinuous glucose monitoring
Description

Continuous glucose monitoring sensor that provides real-time interstitial glucose readings and integrates with Medtronic insulin pumps and smart pen systems.

5Simplera Sensor
CategoryContinuous glucose monitoring
Description

Continuous glucose monitoring sensor positioned by Medtronic for UK users who want CGM data without the full pump-based closed-loop system.

6MiniMed Extended Infusion Set
CategoryInsulin pump consumables
Description

Extended-wear insulin infusion set designed to be used for a longer duration than standard sets, used as a consumable with Medtronic insulin pumps.

7MiniMed Mio Advance Infusion Set
CategoryInsulin pump consumables
Description

Pre-loaded, serter-based insulin infusion set that simplifies insertion for pump users as a pump consumable.

8MiniMed Mio 30 Infusion Set
CategoryInsulin pump consumables
Description

Angled (30°) infusion set consumable for Medtronic insulin pump users requiring angled insertion.

9MiniMed Quick-Set Infusion Set
CategoryInsulin pump consumables
Description

90-degree quick-insertion infusion set used as a standard consumable with Medtronic insulin pumps.

10MiniMed Silhouette Infusion Set
CategoryInsulin pump consumables
Description

Variable-angle, variable-depth infusion set consumable for Medtronic insulin pump users.

11MiniMed Sure-T Infusion Set
CategoryInsulin pump consumables
Description

Steel-cannula infusion set consumable for Medtronic insulin pump users who prefer or require a steel cannula.

12MiniMed Reservoirs
CategoryInsulin pump consumables
Description

Insulin reservoir cartridges used as consumables to fill Medtronic insulin pumps.

13i-Port Advance
CategoryInjection aids
Description

Injection port device that allows people on multiple daily injections to take their shots through a single inserted port rather than multiple skin punctures.

14CareLink Personal
CategoryDiabetes data software
Description

Online diabetes data management platform that lets patients and clinicians review insulin pump, CGM, and Smart MDI therapy data and generate reports.

15WeCare
CategoryPatient support services
Description

Subscription-style patient support program that helps new pump and CGM users get started, including onboarding, training, and ongoing assistance.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeOthers
Description

Medtronic Diabetes benefits from NHS NICE guideline recommendations that call for increased access to diabetes technology including CGM and insulin pump therapy for people with Type 1 and Type 2 diabetes. The updated NICE guidelines (NG17, NG18, NG28) recommend offering real-time CGM and choice of monitoring technologies, potentially expanding the patient population eligible for Medtronic devices through NHS commissioning.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Sanofi is a major diabetes pharmaceutical company that is expanding into digital health and connected diabetes solutions, positioning it as a broad incumbent that intersects with Medtronic's UK diabetes patient ecosystem.

TypeDirect peer
Description

Ypsomed manufactures the mylife YpsoPump insulin pump and is a direct competitor to Medtronic's tubed insulin pump portfolio in the UK and European diabetes care market.

TypeBroad incumbent
Description

Novo Nordisk is a global diabetes leader whose insulin insulins (e.g., NovoRapid, Fiasp) are explicitly supported by Medtronic's InPen, and which is increasingly expanding into connected diabetes devices, making it an adjacent incumbent in the UK diabetes space.

TypeEmerging player
Description

CamDiab develops the CamAPS FX closed-loop algorithm that is interoperable with multiple insulin pumps and CGMs, representing an emerging software layer that could substitute for Medtronic's proprietary SmartGuard and CareLink algorithm stack.

TypeDirect peer
Description

Tandem Diabetes Care produces the t:slim X2 insulin pump with Control-IQ AID algorithm, directly competing with Medtronic's MiniMed 780G in the hybrid closed-loop pump segment across the UK and Europe.

TypeDirect peer
Description

Dexcom is a leading continuous glucose monitor (CGM) manufacturer (G6, G7) that directly competes with Medtronic's Guardian 4 and Simplera CGM systems and is increasingly integrated with multiple AID pump platforms, including in the UK market.

TypeDirect peer
Description

Abbott manufactures the FreeStyle Libre family of CGM sensors, the dominant CGM brand in the UK and a direct competitor to Medtronic's Guardian 4 and Simplera for both Type 1 and Type 2 diabetes patients.

TypeDirect peer
Description

Insulet's OmniPod 5 is a tubeless patch pump with AID capability, directly competing with Medtronic's MiniMed 780G and offering a form-factor alternative in the UK and European insulin pump market.

TypeBroad incumbent
Description

Roche Diabetes Care offers the Accu-Chek portfolio of blood glucose meters, insulin pumps, and digital diabetes management tools, overlapping with Medtronic's diabetes ecosystem in the UK and other European markets.

TypeBroad incumbent
Description

Eli Lilly is a global diabetes leader with insulin and emerging connected delivery offerings, making it a broad incumbent whose products and digital strategy intersect with Medtronic's UK diabetes market.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration20 records

Each record includes

Title, Type, Description, Source

AI maturity
App detail

Has app

Feature8 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Medtronic Ltd

Diabetes Management Devicesmedtronic-diabetes.com

Medtronic Ltd is the UK subsidiary of Medtronic plc, trading as MiniMed. It distributes an integrated diabetes ecosystem — insulin pumps, CGMs, smart pens, and the CareLink data platform — serving Type 1 and Type 2 diabetes patients in the UK via NHS and direct eShop channels.

What Medtronic Ltd does

Medtronic Ltd is the UK operating entity of Medtronic plc (NYSE: MDT), trading under the consumer-facing MiniMed brand and headquartered in Watford, Hertfordshire. The entity operates Medtronic's diabetes business for the United Kingdom only, with related manufacturing at Medtronic MiniMed Inc. (US) and EMEA distribution coordinated through Medtronic International Trading sàrl (Switzerland) and Medtronic BV (Netherlands). Its core offering is an integrated diabetes management ecosystem spanning insulin pump therapy (MiniMed 780G with SmartGuard auto-adjusting algorithm), continuous glucose monitoring (Guardian 4, Simplera), smart insulin pens (InPen, MiniMed Go), and a broad infusion set and reservoir portfolio including the first 7-day wear Extended infusion set. Underlying these devices are the CareLink Personal data platform for therapy reporting and the WeCare personalized onboarding and 24/7 support program, which together aggregate pump, CGM, and pen data from a large installed base.

The business model is a hybrid of regulated medical device hardware sales and recurring software/services revenue. Hardware revenue comes from pump, CGM, smart pen, reservoir, and infusion set sales, with the Extended infusion set and matching reservoir creating a weekly rather than twice-weekly consumables cycle. Software and services revenue is generated through CareLink Personal and the WeCare subscription-style support program. Distribution is dual-track: NHS-funded devices are prescribed and initiated through healthcare professionals (HCPs), with a dedicated HCP portal at hcp.medtronic-diabetes.com, while self-funded patients purchase directly through the UK eShop (self-funded-shop.medtronic-diabetes.co.uk). Customer segments are primarily people with Type 1 diabetes on pump therapy, people with Type 2 diabetes on multiple daily injections (addressed via Smart MDI and MiniMed Go), and the HCPs who prescribe and manage them. The UK entity employs 125 people and operates in a single geography, with growth dependent on NHS commissioning, NICE guideline evolution, and direct-to-consumer channel scaling.

Medtronic Ltd firmographics

Firmographics
Name
Medtronic Ltd
Legal name
Medtronic Limited
Website
https://medtronic-diabetes.com
Company type
Private
Operating status
Operating
Headcount range
101–250 employees
Short description
Medtronic Ltd is the UK subsidiary of Medtronic plc, trading as MiniMed. It distributes an integrated diabetes ecosystem — insulin pumps, CGMs, smart pens, and the CareLink data platform — serving Type 1 and Type 2 diabetes patients in the UK via NHS and direct eShop channels.
Ownership category
akta.pro rank

Medtronic Ltd industry classification

Industry
Product category
Diabetes Management Devices
NAICS
Surgical Appliance and Supplies Manufacturing (339113), Surgical and Medical Instrument Manufacturing (339112), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (33451)
SIC
Surgical & Medical Instruments & Apparatus (3841), Electromedical & Electrotherapeutic Apparatus (3845)
akta.pro industry
PRIMARYHLAHAHAF
Automated Insulin Delivery (AID) / Closed-Loop Systems
Healthcare & Life Sciences/Medical Devices & Diagnostics/Diabetes Care Devices (CGM, Insulin Delivery)
SECONDARYHLAHAIAG
Insulin Pumps & Patch Pumps
Healthcare & Life Sciences/Medical Devices & Diagnostics/Drug Delivery Devices (Injectors, Pumps, Inhalers)
SECONDARYHLAHAHAB
Insulin Pumps (Tubed)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Diabetes Care Devices (CGM, Insulin Delivery)
SECONDARYHLAHAHAD
Smart Insulin Pens & Connected Pen Caps
Healthcare & Life Sciences/Medical Devices & Diagnostics/Diabetes Care Devices (CGM, Insulin Delivery)
SECONDARYHLAHAHAE
Insulin Pen Needles, Syringes & Infusion Sets (Consumables)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Diabetes Care Devices (CGM, Insulin Delivery)
SECONDARYHLAHAHAL
Diabetes Care Device Accessories & Adhesives (Sensors/Pump Supplies)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Diabetes Care Devices (CGM, Insulin Delivery)
SECONDARYHLAHAHAJ
Diabetes Digital Therapeutics & Dose Decision Support (Bolus Calculators)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Diabetes Care Devices (CGM, Insulin Delivery)

Keywords

  • Insulin pump therapy
  • Continuous glucose monitoring
  • Diabetes management devices
  • Smart insulin pen
  • Hybrid closed loop systems

Where Medtronic Ltd is headquartered

Location

Headquarters

HQ city
Watford
HQ country
United Kingdom
HQ region
Europe

Offices1 record

Markets served

Medtronic Ltd business model

Business model
GTM type
B2B and B2C
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Supply Chain, Personnel, Operations, Marketing or Sales

Revenue model

  1. Medical Device Hardware Sales: Sale of insulin pumps (MiniMed 780G, MiniMed 640G, MiniMed 670G), continuous glucose monitors, smart insulin pens, infusion sets, and consumables through direct eShop channel and healthcare provider prescriptions.
  2. Software and Data Services: CareLink Personal cloud platform for device data management, WeCare support services providing personalized onboarding and 24/7 assistance, and mobile app ecosystem.
  3. Extended Infusion Set and Reservoir Consumables: Proprietary 7-day Extended Infusion Set and matching 3.0ml reservoir designed exclusively for use with the Medtronic Extended system, requiring weekly rather than twice-weekly changes.

Go-to-market motion1 record

Distribution channels4 records

Marketing channels6 records

Medtronic Ltd product offering

Product offering

Core offering

Medtronic Ltd operates the UK diabetes business under the MiniMed brand, designing, manufacturing, and selling insulin pumps (MiniMed 780G system), continuous glucose monitors (Guardian 4 and Simplera), the InPen smart insulin pen, infusion sets (Mio Advance, Mio 30, Quick-set, Silhouette, Sure-T, Extended), reservoirs, and supporting software platforms (CareLink Personal, WeCare, MiniMed Mobile and CareLink Connect apps) for people with Type 1 and insulin-requiring Type 2 diabetes.

Product overview

Medtronic Ltd (trading as MiniMed) is the insulin delivery division of Medtronic, offering an integrated ecosystem of diabetes management products. The core offering is the MiniMed 780G system — a hybrid closed-loop insulin pump that automatically adjusts basal insulin delivery based on CGM data. For patients preferring multiple daily injections, the Smart MDI system combines Simplera CGM with the InPen smart insulin pen. The product portfolio spans multiple device categories: insulin pumps (MiniMed 780G), smart insulin pens (InPen, MiniMed Go), CGM sensors (Guardian 4, Simplera), infusion sets (Medtronic Extended, Mio Advance, Mio 30, Quick Set, Silhouette, Sure-T), reservoirs, and injection ports (i-Port Advance). These devices are unified through the CareLink data management platform, which aggregates pump, CGM, and smart pen data for patients and healthcare providers, and supported by the WeCare patient onboarding and support program.

Differentiator

Problem solved

Functional benefit

Brands

  • WeCare: Personalised onboarding programs and 24/7 support services for diabetes patients using Medtronic devices.
  • CareLink
  • MiniMed 780G System
  • MiniMed Go System
  • Simplera CGM
  • InPen Smart Insulin Pen
  • Guardian 4 System
  • SmartGuard

Products and services

  • MiniMed 780G System Automated insulin delivery system for people with Type 1 diabetes, combining an insulin pump, CGM integration, and a hybrid closed-loop control algorithm to automatically adjust basal insulin and correct highs.
  • Smart MDI System Connected insulin pen and CGM-based system for people with insulin-requiring diabetes who manage their condition with multiple daily injections rather than a pump.
  • InPen System Bluetooth-enabled smart insulin pen that records insulin doses, calculates dose recommendations, and shares data with the companion mobile app for MDI users.
  • Guardian 4 Sensor Continuous glucose monitoring sensor that provides real-time interstitial glucose readings and integrates with Medtronic insulin pumps and smart pen systems.
  • Simplera Sensor Continuous glucose monitoring sensor positioned by Medtronic for UK users who want CGM data without the full pump-based closed-loop system.
  • MiniMed Extended Infusion Set Extended-wear insulin infusion set designed to be used for a longer duration than standard sets, used as a consumable with Medtronic insulin pumps.
  • MiniMed Mio Advance Infusion Set Pre-loaded, serter-based insulin infusion set that simplifies insertion for pump users as a pump consumable.
  • MiniMed Mio 30 Infusion Set Angled (30°) infusion set consumable for Medtronic insulin pump users requiring angled insertion.
  • MiniMed Quick-Set Infusion Set 90-degree quick-insertion infusion set used as a standard consumable with Medtronic insulin pumps.
  • MiniMed Silhouette Infusion Set Variable-angle, variable-depth infusion set consumable for Medtronic insulin pump users.
  • MiniMed Sure-T Infusion Set Steel-cannula infusion set consumable for Medtronic insulin pump users who prefer or require a steel cannula.
  • MiniMed Reservoirs Insulin reservoir cartridges used as consumables to fill Medtronic insulin pumps.
  • i-Port Advance Injection port device that allows people on multiple daily injections to take their shots through a single inserted port rather than multiple skin punctures.
  • CareLink Personal Online diabetes data management platform that lets patients and clinicians review insulin pump, CGM, and Smart MDI therapy data and generate reports.
  • WeCare Subscription-style patient support program that helps new pump and CGM users get started, including onboarding, training, and ongoing assistance.

Quantifiable outcome

  • Users achieve mean 80% Time In Range (TIR) with MiniMed 780G using recommended settings
  • +2 more outcomes

Companies that use Medtronic Ltd

Customer profile

Named customers1 record

Segments3 records

Ideal customer profiles3 records

Medtronic Ltd technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration20 records

Feature8 records

Medtronic Ltd partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • National Health Service (NHS)coreOthersMedtronic Diabetes benefits from NHS NICE guideline recommendations that call for increased access to diabetes technology including CGM and insulin pump therapy for people with Type 1 and Type 2 diabetes. The updated NICE guidelines (NG17, NG18, NG28) recommend offering real-time CGM and choice of monitoring technologies, potentially expanding the patient population eligible for Medtronic devices through NHS commissioning.

Scale indicators3 records

Recent moves6 records

Expansion highlights6 records

Medtronic Ltd competitors and assessment

Company assessment

Broad incumbents

  • Sanofi: Sanofi is a major diabetes pharmaceutical company that is expanding into digital health and connected diabetes solutions, positioning it as a broad incumbent that intersects with Medtronic's UK diabetes patient ecosystem.
  • Novo Nordisk: Novo Nordisk is a global diabetes leader whose insulin insulins (e.g., NovoRapid, Fiasp) are explicitly supported by Medtronic's InPen, and which is increasingly expanding into connected diabetes devices, making it an adjacent incumbent in the UK diabetes space.
  • Roche Diabetes Care: Roche Diabetes Care offers the Accu-Chek portfolio of blood glucose meters, insulin pumps, and digital diabetes management tools, overlapping with Medtronic's diabetes ecosystem in the UK and other European markets.
  • Eli Lilly: Eli Lilly is a global diabetes leader with insulin and emerging connected delivery offerings, making it a broad incumbent whose products and digital strategy intersect with Medtronic's UK diabetes market.

Direct peers

  • Ypsomed: Ypsomed manufactures the mylife YpsoPump insulin pump and is a direct competitor to Medtronic's tubed insulin pump portfolio in the UK and European diabetes care market.
  • Tandem Diabetes Care: Tandem Diabetes Care produces the t:slim X2 insulin pump with Control-IQ AID algorithm, directly competing with Medtronic's MiniMed 780G in the hybrid closed-loop pump segment across the UK and Europe.
  • Dexcom: Dexcom is a leading continuous glucose monitor (CGM) manufacturer (G6, G7) that directly competes with Medtronic's Guardian 4 and Simplera CGM systems and is increasingly integrated with multiple AID pump platforms, including in the UK market.
  • Abbott Diabetes Care: Abbott manufactures the FreeStyle Libre family of CGM sensors, the dominant CGM brand in the UK and a direct competitor to Medtronic's Guardian 4 and Simplera for both Type 1 and Type 2 diabetes patients.
  • Insulet Corporation: Insulet's OmniPod 5 is a tubeless patch pump with AID capability, directly competing with Medtronic's MiniMed 780G and offering a form-factor alternative in the UK and European insulin pump market.

Emerging players

  • CamDiab: CamDiab develops the CamAPS FX closed-loop algorithm that is interoperable with multiple insulin pumps and CGMs, representing an emerging software layer that could substitute for Medtronic's proprietary SmartGuard and CareLink algorithm stack.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights6 records

Customer concentration

Medtronic Ltd social profiles

Digital presence

Medtronic Ltd financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Medtronic Ltd leadership team

Management profile

Number of profiles

Medtronic Ltd funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Medtronic Ltd M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Medtronic Ltd

What does Medtronic Ltd do?

Medtronic Ltd operates the UK diabetes business under the MiniMed brand, designing, manufacturing, and selling insulin pumps (MiniMed 780G system), continuous glucose monitors (Guardian 4 and Simplera), the InPen smart insulin pen, infusion sets (Mio Advance, Mio 30, Quick-set, Silhouette, Sure-T, Extended), reservoirs, and supporting software platforms (CareLink Personal, WeCare, MiniMed Mobile and CareLink Connect apps) for people with Type 1 and insulin-requiring Type 2 diabetes.

Is Medtronic Ltd a public or private company?

Medtronic Ltd is a private company. It is classified as corporate owned and is currently operating.

When was Medtronic Ltd founded?

Medtronic Ltd was founded in -1. It employs 101 to 250 people.

Where is Medtronic Ltd based?

Medtronic Ltd is headquartered in Watford, United Kingdom, in the Europe region.

How does Medtronic Ltd make money?

Three revenue lines are on record. Medical Device Hardware Sales are the primary driver. The others are software and Data Services and extended Infusion Set and Reservoir Consumables.

Who are Medtronic Ltd's main competitors?

Broad incumbents on record are Sanofi, Novo Nordisk, Roche Diabetes Care and Eli Lilly. Direct peers are Ypsomed, Tandem Diabetes Care, Dexcom, Abbott Diabetes Care and Insulet Corporation. CamDiab is listed as an emerging player.

Does Medtronic Ltd have an API?

No public API is recorded for Medtronic Ltd.

What industry is Medtronic Ltd in?

Medtronic Ltd's product category is Diabetes Management Devices. Its primary akta.pro industry code is HLAHAHAF, Automated Insulin Delivery (AID) / Closed-Loop Systems, with a secondary code of HLAHAIAG, Insulin Pumps & Patch Pumps. Its NAICS code is 339113 and its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales